fda glp-1 compounding warning october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Non-Traditional Channels: The Compounded GLP-1
Description
GLP-1 Patent Expiry: The Next Big Pharma Race Has Already Begun GLP-1 agonists like semaglutide, tirzepatide, and liraglutide have completely reshaped the global diabetes and obesity landscape
Incretin based therapies with glucagon-like peptide-1 receptor agonists (GLP-1RA) are already established in the treatment of type 2 diabetes
Read firsthand accounts of mood changes, weight loss, and side effects.
Here are our favorite products to support digestion, hydration, and comfort, plus expert-backed tips for finding relief.

Learn about the 7-day schedule, the 5-day half-life, and how to safely manage end-of-week hunger.
This hormone plays a pivotal role in numerous bodily processes, including muscle growth, metabolism, and cellular repair